Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies

Abstract

The combination of liposomal AmB and caspofungin was promising as therapy for IA compared with monotherapy. A trial that includes more patients will be required next to confirm the results of this pilot study.